Splenic marginal zone lymphoma with autoimmune hemolytic anemia
Journal of Medicine and Therapeutics · 2018
DOI: 10.15761/jmt.1000123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicine and Therapeutics, 2018. Verfasst von Jay Suriar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Splenic Marginal Zone Lymphoma (SMZL) is an Unusual, distinct lymphoma characterized by indolent clinical course and prolonged survival, and having some clinical, cellular and immunophenotypical features that differ from other indolent lymphomas.We describe a case of SMZL that presented with autoimmune hemolytic anemia.
Zitieren
APA
Suriar, J., Aye, M., Musadiq, M. M., & Cabot, J. S. (2018). Splenic marginal zone lymphoma with autoimmune hemolytic anemia. Journal of Medicine and Therapeutics. https://doi.org/10.15761/jmt.1000123
Vancouver
Suriar J, Aye M, Musadiq MM, Cabot JS. Splenic marginal zone lymphoma with autoimmune hemolytic anemia. Journal of Medicine and Therapeutics. 2018. doi:10.15761/jmt.1000123
BibTeX
@article{Suriar2018,
author = {Suriar, Jay and Aye, Mra and Musadiq, Mohamed M and Cabot, Jason S},
title = {Splenic marginal zone lymphoma with autoimmune hemolytic anemia},
journal = {Journal of Medicine and Therapeutics},
year = {2018},
doi = {10.15761/jmt.1000123}
}
EUVIMED